Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"English"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=11
/vufind/Search/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=11
Search /vufind/Search2/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=11
PubPharm (127.896)
101
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines : A 52-week Multi-center, Randomized, Double-blind, Placebo Controlled, Basket Study With an Open-label Extension to Investigate the Efficacy, Safety, and Tolerability of Remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in Adults Inadequately Controlled by H1-antihistamines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
102
A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. : A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
103
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis : A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
104
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer : A Randomized, Phase 3, Open-label Study to Evaluate SGN-B6A Compared With Docetaxel in Adult Subjects With Previously Treated Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
105
A Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo and With Omalizumab as Active Control in CSU Adult Patients. : A Global, Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib 25 mg b.i.d. in Comparison to Placebo With Omalizumab 300 mg Every 4 Weeks as Active Control Over 52 Weeks in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by Second-generation H1-antihistamines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
106
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy : Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
107
Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa : A Phase 3, Randomized, Open-label, Parallel-arm, Active-controlled, Multicenter Study to Evaluate Safety and Efficacy of ALXN1850 Versus Asfotase Alfa Administered Subcutaneously in Pediatric Participants (2 to < 12 Years of Age) With Hypophosphatasia (HPP) Previously Treated With Asfotase Alfa
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
108
Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa : A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN1850 (Recombinant Alkaline Phosphatase) Administered Subcutaneously in Adolescent (12 to < 18 Years of Age) and Adult Participants With Hypophosphatasia Who Have Not Previously Been Treated With Asfotase Alfa
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
109
Clemastine Treatment in Individuals With Williams Syndrome : Clemastine Treatment in Individuals With Williams Syndrome- a Double-blind Placebo Control to Assess the Safety and Efficacy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
110
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera : Randomized, Open-label, Multicenter Phase 3 Study to Assess the Efficacy and Safety of GIVinostat Versus Hydroxyurea IN JAK2V617F-positive High-risk Polycythemia Vera Patients: the GIV-IN PV TRIAL
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[12790]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Sprache: Englisch
Filter aufheben
Thema: Phase: Phase 3
Medienart
127.896
Aufsätze
127.896
E-Artikel
127.896
E-Ressourcen
Zeitschriftentitel
92.284
WHO International Clinical Trials Registry Plat...
35.612
ClinicalTrials.gov
Thema
127.896
610
Phase: Phase 3
127.892
Study Type: Interventional
51.637
Recruitment Status: Not yet recruiting
28.323
Recruitment Status: Completed
23.152
Recruitment Status: Authorised-recruitment may ...
9.746
Recruitment Status: Recruiting
3.159
Recruitment Status: Terminated
2.840
Recruitment Status: Active, not recruiting
2.253
Recruitment Status: Unknown status
1.560
Recruitment Status: Complete: follow-up complete
1.276
Diabetes Mellitus
1.146
Diabetes Mellitus, Type 2
1.007
Recruitment Status: Withdrawn
957
Breast Neoplasms
797
Hypertension
793
Syndrome
767
Carcinoma
690
Recruitment Status: Closed to Recruitment of Pa...
658
Carcinoma, Non-Small-Cell Lung
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
79.045
2020-
47.125
2010-2019
1.726
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Englisch
Haven't found what you're looking for?
Wird geladen...